Abstract The objective of this study is to provide a critical overview of available instruments to assess impairments in patients with rheumatic disorders, and to recommend reliable and valid instruments for use in allied health care and rehabilitation medicine. A computer-aided literature search in several databases was performed to identify studies focusing on the clinimetric properties of instruments designed to assess impairments in function in patients with rheumatic disorders. Data on intra-rater reliability, interrater reliability and construct validity were extracted in a standardized way. Explicit criteria were applied for reliability and validity. Results: The search identified a total of 49 instruments to assess impairments in functions in patients with rheumatic disorders; 19 met the criteria for reliability, 22 met the criteria for validity, and 11 out of the 49 appeared to meet the criteria for both reliability and validity. In summary, evidence of both reliability and validity was only found for 11 out of 49 instruments for the assessment of impairments in patients with rheumatic disorders. Only a limited number of the identified instruments for the assessment of impairments is both reliable and valid. Allied health care professionals should be cautious in the selection of measurement instruments to assess their patients.
Introduction
In rehabilitation medicine and allied health care for patients with rheumatic disorders, attention has shifted from disease severity to impairments, disabilities and problems in participation [1] . In particular, the development of the International Classification of Impairments, Disabilities and Handicaps (ICIDH) [2] -after its revision in the past decade now renamed the International Classification of Functioning, Disabilities and Health Problems (ICF) [3] -has encouraged this shift. The ICF distinguishes the disease itself from disease consequences and influencing contextual factors. In rehabilitation medicine and allied health care, the treatment goals cannot directly be derived from the severity of the disease. If the treatment goals are expressed in terms of impairment, disability or problems in participation (as in the ICF), these must be assessed and objectified [4, 5] .
From this point of view it is essential to choose adequate measurement instruments, based on the evidence of their methodological quality [4, [6] [7] [8] [9] [10] [11] .
This study focuses on the psychometric properties of instruments to measure impairments in functions in the body and structures of patients with rheumatic disorders, a population which is frequently treated with physiotherapy and occupational therapy. ''Impairment'' is defined as any significant loss or abnormality of psychological, physiological or anatomical structure or function. Impairment is part of a health condition, but does not necessarily indicate that a disease is present or that the individual should be regarded as sick [12] . ''Disabilities'' are defined as limitations in the performance of a task or action by an individual [12] . We recently demonstrated that 57% of all available instruments to assess people with rheumatic disorders focus on impairments [13] . We started to focus on instruments to measure impairments because of this dominance. In the majority of clinical situations (60%), instruments are used to measure status praesens of the patient [13] .
Inter-rater and intra-rater reliability are the first characteristic of an instrument that are required to be adequate; if a measurement is not reproducible it will not be useful. Furthermore, an important requirement of a measurement scale is the unidimensionality of subscales. If sufficient reliability has been demonstrated, it is also relevant to assess the validity.
In the literature, several aspects of validity are described, but construct validity is the most commonly assessed aspect. An instrument can be validated by studying its correlation with an optimally-comparable construct (e.g., the same impairment) or by correlation with an imperfect construct, such as gender, age, etc. In this study we distinguished various levels of construct validity, because we expected to find higher correlation values if measurement instruments were validated against an optimally-comparable construct than if validated against an imperfect construct [14] . If so, this could be relevant for interpretation of validity studies.
The aim of this study was threefold. The first objective was to make an inventory of available instruments and questionnaires for the assessment of impairments in patients with rheumatic disorders. The second aim was to investigate which of these instruments have acceptable methodological quality with regard to reliability and validity. The third aim was to investigate the assumption that construct validity results in higher correlation values when validated against a more suitable construct.
Method and materials
We performed a systematic review of the literature on the methodological characteristics of measurement instruments for all impairments that are relevant in allied health care for patients with rheumatic disorders. The term ''measurement instrument'' includes questionnaires (to be completed by the patient), observation lists (to be completed by the researcher) and anthropometric measurement instruments (technical measurement tools). Not all reported properties of instruments are appropriate for all kind of instruments. For example, inter-rater reliability (the degree to which two or more observers can obtain the same ratings) is inappropriate for questionnaires that are completed by the patient.
Inclusion procedure
The following criteria were applied: -All studies had to focus on patients suffering from rheumatoid arthritis, seronegative polyarthritis (including psoriatic arthritis), osteoarthritis, ankylosing spondylitis, polymyositis or fibromyalgia. -The studies had to contain information about the psychometric properties of instruments to assess impairments in mental functions, stiffness, pain, joint mobility (in terms of Range of Motion), muscle force and swelling (ICIDH-classification) [15] . -Many questionnaires focus on more than one domain of the ICIDH-classification, or measure more than one variable. Included were: (1) instruments which focus mainly (50% or more of the items) on the impairment to be measured; and (2) questionnaires with a sub-scale for the impairment in question that can be interpreted separately as a single entity. -Different versions of an instrument were considered as separate measurement instruments. -Only instruments for the measurement of adult patients were included.
Because of the method of data-reduction as described above, some frequently-used questionnaires, like the Health Assessment Questionnaire (HAQ), or the Western Ontario McMaster Osteoarthritis Index (WO-MAC), the EuroQoL and Nottingham Health Profile are not included. The condition to be included was that 50% or more of the items should focus on the impairment to be measured. Questionnaires like HAQ, WO-MAC and Nottingham Health Profile predominantly focus on disabilities.
Literature search
First the Medline database was searched for the period January 1982-May 2004, using search terms for the relevant rheumatic disorders and various search terms for psychometric properties 1 . The database of the Centre for Documentation of the Dutch Institute of Allied Health Care was also searched for the period January 1988-May 2004, using the same keywords. Furthermore, the search in both databases was repeated with the names of the identified measurement instruments. English, French, German and Dutch literature was included. The search was subsequently augmented with a manual search based on the references of the relevant publications, and therefore the search also yielded some publications from before 1982. In total, 156 measurement instruments were identified.
Data-extraction
All identified publications were assessed independently on the basis of their title, and abstract by two reviewers (RS and YK). In case of disagreement (3%) the article was also assessed by a third reviewer. The assessment was based on a standardized data-collection form (R.A.B. Oostendorp et al., unpublished data). This form consists of four sections: general description (name, first author, etc.), assessment domain (according to the ICIDH-classification), methodological aspects (concerning reliability, validity) and aspects of utilization.
Methodological criteria for psychometric properties
We investigated the following psychometric properties: intra-rater reliability, inter-rater reliability, construct validity and responsiveness. To interpret the data on reliability and validity we used criteria based on De Jong et al. Table 1) .
The cut-off points for ''good'' reliability are supported by Weiner and Stewart, who also suggested 0.85 as a criterion [20, 21] .
To investigate the influence of validating against different constructs (varying from optimally comparable to imperfectly comparable) the construct validity was divided into five clusters, in which the constructs against which a measurement instrument is validated are defined according to their anticipated degree of similarity to the instrument at issue ( Table 2) .
''Construct 1'' is the most convergent construct, which means that the validity is measured against a variable which is very similar to the variable to be validated (e.g., a pain-intensity questionnaire [variable pain] that is validated against a Visual Analogue Scale for pain). Validity is defined as ''construct 2'' if the instrument is validated against instruments that measure the same construct as well as other impairments. ''Construct 3'' indicates that the construct relates to other impairments than the impairment to be validated. ''Construct 4'' relates to disabilities, and not to impairments. ''Construct 5'' is the least convergent validity, which means that the construct that is used to validate a variable relates to other domains than the variable that is to be validated (e.g., a painintensity questionnaire (variable pain) that is validated against disabilities in inter-personal relationships).
We clustered ''construct 1'' and ''construct 2'' as ''optimally-convergent validity'' and ''construct 3'', ''construct 4'' and ''construct 5'' as ''imperfectly-convergent validity''. This distinction is also reflected in the criteria for validity in the two last columns of Table 1 . The argument for this distinction is the fact that optimally-convergent construct validity comes closest to the gold standard, and is therefore expected to result in higher values than imperfectly-convergent validity [14] . An explanation of all the abbreviations used in the ''Result'' section is given in the Appendix.
Data analysis
The data were analysed in the Statistical Package for Social Sciences (SPSS) 8.0. A classification of instruments was first made according to the type of impairments, based on the domain of assessment (impairments) [12] .
The values of different studies of the same instrument were pooled for each psychometric property that was assessed (reliability and construct validity, related to sample size and correlation coefficients). By means of statistical pooling taking sample sizes into account, the results of separate studies on reliability and constructed validity, expressed in correlation coefficients, were combined into a single index. When the relevant information was available, mathematical pooling of the data was performed if the measurement instrument was validated against the same construct. The values were pooled per construct. The pooled index is composed of measurements, appropriately weighted:
where X = pooled index, n i = number of persons included in the study, x i = value of methodological aspect (Pearson's r, Spearman's q or intra-class correlation coefficient (ICC)) in the study, N = total number of persons in all studies included in the pooling [22] . The pooled index was computed for Pearson's/Spearman's correlation coefficients and the ICC values separately. Values for the construct validity of multidimensional instruments can be strongly influenced by values of one Table 1 Applied cut-off points for intra-rater reliability, interrater reliability and construct validity x = Pearson's r, Spearman's q or intra-class correlation coefficient (ICC).
Intra-rater reliability
Inter-rater reliability Table 2 Categorization of comparators utilized in assessing construct validity
Construct level Definition
Construct 1 Validation against sub-scales or instruments that measure the same impairment Construct 2
Validation against instruments that measure the same impairment as well as other impairments Construct 3
Validation against instruments that measure other impairments than the instrument to be validated Construct 4
Validation against instruments that measure disabilities instead of the domain (impairments) to be validated Construct 5
Validation against generic instruments that measure impairments as well as disabilities and participation problems or more sub-scales. Therefore, whenever possible, the data were also pooled for the separate sub-scales.
Results Table 3 presents the impairments in the ICIDH-classification that are considered to be relevant for people with rheumatic disorders in allied health care settings.
The number of identified instruments is also shown for each group of relevant impairments. In total the search identified 49 measurement instruments for the assessment of impairments in functions in patients with rheumatic disorders (Table 3) . Several of these 49 instruments measure more than one impairment. Two adapted versions of the AIMS, a multidimensional questionnaire, are included: the AIMS2 and the AIMSS (for all abbreviations see the Appendix). As can be observed in Table 3 , the categories of impairments that are most frequently assessed by measurement instruments are pain (n=20; 41%) and impairments in musculoskeletal and movement related functions (n=15; 33%).
With regard to stiffness, the Visual Analogue ScaleStiffness and Morning Stiffness-Duration measure only stiffness. The BASDAI also measures other aspects of disease activity, such as (joint) pain, swelling and tiredness. Impairments in sensory functions are mainly assessed by instruments that focus on pain, with only one exception (the AIMS). Fifteen measurement instruments that were identified only measure impairments in musculoskeletal and movement-related functions. Six of these instruments have been specifically developed for assessing patients with ankylosing spondylitis.
Measurement of impairments in mental functions of patients with rheumatic disorders
Most instruments that measure impairments in mental functions of patients with rheumatic disorders (they all concern questionnaires) do not only measure these impairments, but also other impairments and/or disabilities. Four instruments that were identified focus only and specifically on impairments in mental functions (AHI, BDI, SSAI and STAI); the SF-36 and the AIMS and its modifications have only a sub-scale for measuring mental health, and focus mainly on disabilities.
The AIMS, in different modifications, is the only questionnaire that meets the criterion for reliability (Table 4) . For the most convergent construct validity (validated against an optimally-comparable construct), two questionnaires meet the criterion: BDI (pooled r=0.67), and STAI (pooled r=0.68). For the imperfect construct validity, another two questionnaires can be qualified as ''good'': the AHI (pooled r=0.69) and the AIMS-depri (pooled r=0.74). None of the identified instruments had good reliability as well as good validity.
Measurement of impairments in sensation: stiffness
There are three available instruments to measure stiffness: BASDAI, MS-D and VAS-S (Table 4) . In all three, the intra-rater reliability is good. There is a great variety in the validity of these instruments, with values that range from 0.26 to 0.70 if validated against instruments that measure the same impairment (Table 4). The highest value is found for the BASDAI (r=0.70). Only the BASDAI and the VAS-S have good reliability as well as good validity (shown in italics in Table 4 ).
Measurement of impairments in sensory functions: pain
In total, 20 measurement instruments were identified for the assessment of pain in patients with rheumatic disorders (two modifications of the AIMS included). Eight out of these 20 only measure (modalities of) pain: AI, Dol, MPQ, OPB, P-NRS, RAPS, RPS and VAS-P. All the others are multidimensional instruments, or represent a separate sub-scale for pain in a multidimensional instrument. The results are presented in Table 4 .
Reliability studies were performed for all the 20 measurement instruments, with the exception of the EI, the P-NRS and the RPS. Five of the instruments showed good reliability: AIMS (pooled r =0.86), AIMS2-pain (ICC=0.89), ASES (pooled r =0.88), AUSCAN (ICC=0.89), J-MAP (internal consistency=0.90) and RAPS (internal consistency=0.92).
Seven instruments showed good convergent construct validity, with the highest values for the AI, the Dol and the VAS-P. Seven instruments were found to have imperfect construct validity, all by correlation with composite measurement instruments, combining impairments, disabilities and problems in participation in one measure. If reliability and construct validity are both required to be ''good'', the AIMS and the AU-SCAN-OHI are the only suitable instruments for pain assessment. 
Measurement of impairments in joint mobility
For the assessment of joint mobility in patients with rheumatic disorders, 11 measurement instruments were identified (Table 4) . On the basis of the available data, all instruments meet the criterion for intra-rater reliability, with the exception of the EDI. For the BASMI and the spondylometer there is no available information concerning reliability. The same was found for the interrater reliability, with the exception of Chest-expansion (ICC=0.53), and MobSpine-CCD (ICC=0.72). The BASMI (pooled r =0.93), the goniometer (r =0.92) and the spondylometer (r =0.92) prove to be valid in patients with rheumatic disorders if validated against an optimally comparable construct. If the validity is based on correlation with an imperfect construct, the EPM and Shobert's test can also be qualified as valid. If both reliability and validity are required to be ''good'', four measurement instruments meet the criteria: the Chestexpansion, the EPM, the goniometer and Shobert's test.
Measurement of impairments in muscle force
Three instruments were identified to measure impairments in muscle force in patients with rheumatoid arthritis. The Grippit and the MSI are only intended to measure hand muscles, but the sphygmomanometer can also be used for other muscle groups (Table 4) . Only the sphygmomanometer meets the criteria for both reliability and validity (reliability r =0.93; construct validity r =0.87(pooled)).
Measurement of impairments in swelling
Two instruments are described for the assessment of (joint) swelling, both of which are sub-scales of an instrument to assess disease activity ( Table 4) .
The AI meets the criterion for inter-rater reliability (pooled r =0.82). The validity of the AI (r =0.88) and the SAJ (r =À0.65) was investigated. The AI was found to be the best instrument to assess joint swelling in patients with rheumatic disorders.
Consequences of distinguishing convergent construct validity (validated against an optimally-comparable construct) vs divergent construct validity (validated against an imperfect construct)
Summarizing the data on measurement instruments for relevant impairments, data on the validity of 40 instruments and/or sub-scales are available. For 21 out of these 40 measurement instruments, there are data on the optimally-comparable construct validity as well as the imperfect construct validity. In 14 of those 21 instruments, the correlation values for the optimally-comparable constructs proved to be higher than the values for validation against the imperfect constructs. In those studies reporting that the validity based on the imperfect constructs was better, in four out of six cases it concerned the AIMS, or modifications or sub-scales of the AIMS.
Discussion
We identified 49 instruments for the assessment of impairments in mental functions, stiffness, pain, joint swelling, mobility and muscle strength in patients with rheumatic disorders. Sixteen of these instruments were found to have good reliability, and 24 were found to have good validity. Only 9 out of the 49 measurement instruments had good reliability as well as good validity. None of the identified instruments for the assessment of impairments in mental functions were both reliable and valid. With regard to the other impairments, only one to three instruments per impairment met the criteria for reliability as well as validity. For assessment of stiffness, the best instruments are the BASDAI and the VAS-S. For assessment of pain the best instrument is the AIMS. For joint mobility, Chest, EPM and Gonio are the best available instruments, for muscle force the Sphy, and finally, for assessment of (joint) swelling the best instrument is the AI. The best available instruments are given in italics in Table 4 .
Clinical consequences of this study
Many measurement instruments are developed for the assessment of impairments in people with rheumatic disorders. For clinical use, unidimensionality, good reliability and good validity are required for a useful application. The question is not what kind of new instruments should be developed, but rather which of the existing measurement instruments should be rejected because of insufficient quality or lack of information about their psychometric properties. For at least seven instruments there is a lack of information concerning their reliability. This might be a consequence of the fact that this review was restricted to studies focusing on populations with rheumatic disorders. The reliability and validity of the instruments might well have been investigated in other patient populations. The results of this review show that six instruments had insufficient reliability as well as insufficient validity, so there is evidence to justify rejection of those six instruments for populations with rheumatic disorders: MS-D, ADLps, MPQ, P-NRS, RPS and EDI-abd.
Many questionnaires that are intended to be used by people with chronic diseases are multidimensional in order to get as complete an overview of the impact of the disease as possible. However, this multidimensionality makes validation of the questionnaire more complex. It may be easier to find an optimally-comparable construct to validate against for unidimensional questionnaires than for a multidimensional questionnaire. For that reason we analysed data for the separate sub-scales if possible, in order to study the influence of the validity of subscales on the validity of the total questionnaire. The assumption is that each sub-scale is unidimensional, which is the first requirement of a measurement scale and also requires a good internal consistency.
It is remarkable that unsatisfactory validity was found for several sub-scales of the AIMS; namely, the AIMS-pain, AIMSS-pain, AIMS-anxiety, AIMS-depri and AIMS-emof. Those (sub-)scales were especially developed to assess a specific impairment, so one would expect them to have high correlation values if validated against an optimally-comparable construct. The reliability of sub-scales of the AIMS has not been investigated. Research on this topic is restricted to the AIMS as a whole. On the basis of our results it could be concluded that the AIMS as a whole is reliable and valid, but that there is insufficient evidence for ''good'' psychometric properties of separate sub-scales of the AIMS. Furthermore, restrictions to this conclusion must be made because of the fact that the conclusion regarding the validity of the AIMS as a whole is based on comparison with an imperfect construct. In fact, in general, construct validity is a way of hypothesis testing, where the hypothesis is hidden in the hypothetical (theoretical) constructs. The hypothetical constructs contain proposed underlying factors (which we tried to classify in Table 2 ). Possibly the proposed underlying factors (which are also incorporated in the different items of a questionnaire) are not fully correct, which might also explain the differences found in correlations. In fact, the results of construct validity must be interpreted in a broader context than only the strength of correlation with other measures. It is often advocated in the literature that validity is also related to reliability and internal consistency, as well as to the proposed underlying factors in the hypothetical constructs. The results of our study should be interpreted in the light of this.
Despite the classification of constructs into ''convergent constructs'' vs ''imperfectly-convergent constructs'' and our expectation to find stronger correlations in validation against ''convergent constructs'', our results did not confirm this in 100% of cases. In particular, some impairment-measures showed strong correlations when validated against disabilities. This could possibly be explained by the fact that some impairments are good predictors for certain disabilities. For example ''depression'' (AIMS-depri) will have a relative strong impact on disability and participation problems (correlation r =0.74; Table 4 ).
The majority of instruments to measure joint mobility were found to have good intra-and/or inter-rater reliability. Some of the instruments are designed for specific groups of patients: for measuring mobility in patients with ankylosing spondylitis, the most reliable and valid available instruments are the Chest-expansion measurement and Shobert's test. For patients with rheumatoid arthritis the best option is the EPM-ROM.
For all rheumatic disorders, in general, the best options are the goniometer, the spondylometer and the BASMI.
The sphygmomanometer is the most reliable and valid instrument to assess muscle strength. It is mainly used for the assessment of grip strength, but can also be applied to assess the strength of other muscles [119] . When assessing grip strength in particular, the sphygmomanometer can measure isometric muscle strength reliably and quickly.
In this study we did not report the responsiveness of the identified instruments. So far, research into the responsiveness of measurement instruments is hampered by the lack of consensus about the preferred method. Further research is needed to investigate the responsiveness of the identified instruments in the assessment of impairments.
In this study, several levels of construct validity were distinguished. We only accepted a value of ‡0.50 as ''good'' if validated against an imperfect construct, and a value of ‡0.65 as ''good'' if validated against an optimally-comparable construct. Our cut-off points are based on the literature, but in fact many authors seem to deviate from literature when interpreting the results of their own study [106, [124] [125] [126] . To our knowledge, different cut-off points for optimally-convergent validity vs imperfectly-convergent validity have never before been applied in validation studies. The results of our study demonstrate that the use of different cut-off points is justified; most measurement instruments showed better correlations with optimally-comparable constructs than with imperfect constructs, and this information is relevant for the interpretation of validity studies in general. However, the levels of the cut-off points applied in this study remain arbitrary. Regarding correct interpretation of the cut-off points for ''good'' reliability, it must be emphasized that these also depend on the sample size, since a sample size of 1,000 can tolerate a much less reliable instrument than a sample of 10 [21] . The aim of our study was to give an overview of reliability of instruments, intended for individual use in clinical situations. As a consequence of pooling data, the total number of patients generating our results is large; therefore, a high cut-off point is required to justify extrapolation to level of individuals.
The workgroup Outcome Measures in Rheumatoid Arthritis Clinical Trials
The workgroup Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) also emphasizes the importance of the methodological quality of measurement instruments. OMERACT established a core set of eight end-points that should be evaluated in clinical trials (disease activity, disability, pain, patient global assessment, physician global assessment, swollen joint, tender joint, and joint imaging) [127, 128] . The instruments discussed in this article focus on two of these domains (pain and the number of tender joints). The results of our study might also be useful in selecting the most appropriate measurement instrument(s) to assess joint swelling and pain.
In summary, evidence of both reliability and validity was only found for 11 out of 49 instruments for the assessment of impairments in patients with rheumatic disorders. Those 11 best instruments are reflected in bold in Table 4 . In six instruments neither the reliability nor the validity was found to be adequate. Evidence concerning the reliability and validity of sub-scales of the AIMS is lacking. 
